Roshidah has more than 25 years experience in financial management, corporate strategy development, governance and risk management in various organisations across diverse industries, i.e., upstream oil and gas; pharmaceutical manufacturing and distribution; construction and engineering, with operations in Malaysia and abroad.

Roshidah started her career as an auditor at Deloitte and Touche (Kassim Chan & Co) in 1989. She left the firm in December 1992 to join Time Engineering Berhad as a Group Accountant. In January 1995, Roshidah moved to Remedi Pharmaceuticals (M) Sdn Bhd (Remedi) to head the Finance Department. She was involved in the merger and acquisition of Remedi, Raza Manufacturing Berhad and Strand Pharmaceuticals Sdn Bhd by Pharmaniaga Berhad (Pharmaniaga) in 1998 and the subsequent public listing of Pharmaniaga on Bursa Securities in 1999. In January 2000, Roshidah was promoted as the General Manager Finance and later in April 2003, as the Chief Financial Officer for Pharmaniaga. She was also the Chief Operating Officer of Pharmaniaga from 2006 to March 2008. Roshidah then spent the next two years until early 2010, as the Finance Director at UEM Group Berhad and UEM Builders Berhad before she returned to Pharmaniaga to assist the Company to, amongst others, finalise its negotiation for renewal of the concession agreement and prepare for the change in controlling shareholders. After leaving Pharmaniaga in March 2011, she had a short stint as a business consultant. From April 2013 to October 2016, she was the Chief Financial Officer of Sumatec Resources Berhad.

Bank Muamalat Malaysia Berhad

NIL

NIL

NIL